Publications by authors named "Yann Bakoukou"
Article Synopsis
- Gliomas are the most common and aggressive brain tumors, with glioblastoma patients experiencing a low median survival of only 14 months despite current treatments.
- This study analyzed the role of the immune checkpoint BTN3A1 in 34 Moroccan glioma patients, confirming findings in a larger database and focusing on its expression in glioblastoma.
- High BTN3A1 expression was linked to poorer patient prognosis and a more immunosuppressive environment, indicating that targeting BTN3A1 could be a promising new treatment strategy for advanced gliomas.
